3F8 is a selective GSK-3beta inhibitor that can be used as a new tool and potential therapeutic candidate compound for GSK3-related diseases, and can be used in the study of neurological disorders and cancer.
Molecular Weight:
286.28
Purity:
98.49%
CAS Number:
[159109-11-2]
Formula:
C15H14N2O4
Target:
GSK-3
T22180
* VAT and and shipping costs not included. Errors and price changes excepted